The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $16.30 down -2.80% from its previous closing price of $16.77. In other words, the price has decreased by -$2.80 from its previous closing price. On the day, 0.6 million shares were traded. CGEM stock price reached its highest trading level at $16.895 during the session, while it also had its lowest trading level at $16.035.
Ratios:
For a deeper understanding of Cullinan Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 05 ’24 when Michaelson Jennifer sold 8,000 shares for $16.33 per share. The transaction valued at 130,640 led to the insider holds 123,942 shares of the business.
Michaelson Jennifer sold 5,606 shares of CGEM for $168,516 on May 07 ’24. The Chief Scientific Officer now owns 129,582 shares after completing the transaction at $30.06 per share. On May 06 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 58,000 shares for $28.07 each. As a result, the insider received 1,628,159 and left with 129,582 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 972268864 and an Enterprise Value of 285258240.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -13.33%, while the 200-Day Moving Average is calculated to be 1.22%.
Shares Statistics:
For the past three months, CGEM has traded an average of 829.16K shares per day and 768180 over the past ten days. A total of 42.90M shares are outstanding, with a floating share count of 40.92M. Insiders hold about 29.42% of the company’s shares, while institutions hold 45.79% stake in the company. Shares short for CGEM as of 1721001600 were 7893041 with a Short Ratio of 10.08, compared to 1718323200 on 4520539. Therefore, it implies a Short% of Shares Outstanding of 7893041 and a Short% of Float of 15.9.
